Aggressive statin treatment provides cardiovascular risk reduction and pleiotropic beneficial effects for patients with carotid artery disease and hypercholesterolemia.
Does statin therapy improve cardiovascular outcomes in patients with carotid artery disease and stroke?
Aggressive statin treatment is crucial for cardiovascular risk reduction and provides pleiotropic benefits in patients with carotid artery disease.
Hypercholesterolemia is a risk factor for carotid artery stenosis and stroke. Statins are the main drugs for the management of hypercholesterolemia and they are strongly recommended by international guidelines for the management of vascular patients. The present review will focus on the associations between cholesterol, carotid artery stenosis and stroke and will cover several topics, including the conservative and perioperative/periprocedural management of carotid patients, the effect of statins on contrast-induced nephropathy developing after endovascular carotid interventions, the role of statin loading prior to endovascular procedures, as well as the indirect beneficial effects of statin treatment on renal function. It will also discuss the topics of statin intolerance and alternative cholesterol-lowering options for statin-intolerant vascular patients. Cholesterol levels play a prognostic role in carotid patients with regards to both short- and long-term stroke and mortality rates. Physicians should keep in mind the pivotal role of cholesterol levels in determining cardiovascular outcomes and the pleiotropic beneficial effects associated with statin use and should not miss the opportunity for cardiovascular risk reduction with aggressive statin treatment.
Paraskevas et al. (Thu,) conducted a review in Carotid artery stenosis and stroke. Statins was evaluated. Aggressive statin treatment provides cardiovascular risk reduction and pleiotropic beneficial effects for patients with carotid artery disease and hypercholesterolemia.